Home » Newsletters » BioWorld Science

BioWorld Science

July 8, 2015

View Archived Issues

Autologous human bone marrow-derived mononuclear stem cells used for diabetic critical limb ischemia

MedImmune characterizes dual GLP-1/glucagon agonist for obesity

Galderma discloses new preclinical models for neurogenic skin disorders

Evofem seeks U.S. approval of Amphora as contraceptive

Innate Pharma receives initial payment from AstraZeneca under IPH-2201 agreement

First-in-human study testing Oncoceutics' ONC-201

Progenics Pharmaceuticals to conduct phase III trial of 1404

Allergan enters into licensing agreement with Merck & Co. for CGRP migraine program

Dyax's DX-2930 receives FDA breakthrough therapy designation

FDA approves Entresto to reduce risk of cardiovascular death and heart failure hospitalization

Prima Biomed receives positive scientific advice from the EMA for IMP-321

Trophogen awarded second year of phase II SBIR grant

Roche divulges BACE1 inhibitors

Esteve reports sigma1 and mu-opioid receptor ligands

Sanofi patents AMPK activators

GlaxoSmithKline discloses KMO inhibitors

AbbVie develops BRD4 inhibitors

Incyte and Vanderbilt University Medical Center form oncology research collaboration

Allergan to acquire ocular device developer Oculeve

Cortactin identified as biomarker, possible therapeutic target in CLL

DSMB recommends continuation of Genticel's phase II trial of ProCervix

Hetlioz approved in the E.U. for non-24-hour sleep-wake disorder in totally blind adults

GNI initiates Chinese pilot study of Etuary for radiation-induced pneumonitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...